Cargando…
Factor Xa Inhibition, A New Strategy for Prevention of Adverse Cardiac Remodeling in Early Stages?
[Figure: see text]
Autor principal: | Bozkurt, Biykem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000877/ https://www.ncbi.nlm.nih.gov/pubmed/32043487 http://dx.doi.org/10.1016/j.jacbts.2019.12.008 |
Ejemplares similares
-
High‐Sensitivity Cardiac Troponin: From Patient Phenotypes to Clinical Events in Patients With Heart Failure With Preserved Ejection Fraction
por: Bozkurt, Biykem
Publicado: (2018) -
Pulmonary vein remodeling in hypertension: Mechanistic insight into primary prevention of atrial fibrillation
por: Iwasaki, Yu-ki
Publicado: (2018) -
Searching for the key to improve infarcted cardiac wall motion and prevent ventricular remodeling after ST-segment elevation myocardial infarction: Beyond symptom-onset-to-balloon time
por: Jeong, Myung Ho
Publicado: (2015) -
Metabolic Reprogramming After Left Ventricular Assist Device: Remodeling Without Recovery of Cardiac Energetics
por: Rame, J. Eduardo, et al.
Publicado: (2016) -
Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction
por: Yurista, Salva R., et al.
Publicado: (2020)